Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

A W R van Kuijk; M de Groot; S O Stapel; B A C Dijkmans; G J Wolbink; P P Tak

doi:10.1136/ard.2009.108787

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article Text

Letter

Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

https://doi.org/10.1136/ard.2009.108787

Statistics from Altmetric.com

Footnotes

Competing interests BACD is a member of the advisory board of Abbott and has received honoraria for lectures. PPT has served as a consultant to Abbott, Schering-Plough, UCB and Wyeth.
Ethics approval Ethics committee approval from Academic Medical Centre/University of Amsterdam.
Patient consent Patient consent received.
Provenance and peer review Not commissioned; externally peer reviewed.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Statistics from Altmetric.com

Footnotes

Read the full text or download the PDF:

Log in using your username and password

Read the full text or download the PDF:

Log in using your username and password